JD Supra

CMS finalizes mandatory GLOBE Model implementing Most Favored Nation drug pricing in Medicare Part B

On September 30, 2026, the Centers for Medicare & Medicaid Services (CMS) finalized a rule to implement a mandatory Most Favored Nation (MFN)-based drug pricing model in Medicare Part B: the Global ...
Medical Daily

Medicare Finalizes GLOBE Model Tying Some Part B Drug Rebates to Foreign Prices, with Far Smaller Savings

A study tied modest frailty gains in a prehab program to lower waitlist death risk in liver transplant candidates. Here is what caregivers can ask the care team. Volunteers found the invented curses ...
The American Journal of Managed Care

CMS Finalizes Mandatory GLOBE Model to Test Lower Part B Drug Costs

CMS finalized the mandatory GLOBE Model, tying Part B drug rebates to international prices in areas covering 25% of beneficiaries from Jan. 1, 2027. A finalized mandatory model will test whether tying ...
JD Supra

CMS Releases MFN Drug Pricing Models for Medicare Parts B and D and Medicaid Amid Trump Administration’s Push for Direct-to-Consumer Strategy

On December 19, 2025, the Centers for Medicare & Medicaid Services (CMS) released GLOBE (Global Benchmark for Efficient Drug Pricing Model) and GUARD (Guarding U.S. Medicare Against Rising Drug Costs) ...
pharmaphorum

GLOBE model finalised, with narrowed scope and fewer savings

The Centers for Medicare and Medicaid Services (CMS) has finalised a new drug pricing policy for Medicare that has drawn sharp criticism from the pharma industry. The Global Benchmark for Efficient ...